Allergan inc (AGN)
Balance Sheet / TTM
Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Dec'08
ASSETS
Current assets:
Cash and equivalents

4,911

3,910

3,189

2,815

3,046

2,686

2,484

2,198

2,701

2,655

2,368

2,291

2,406

2,212

1,856

2,530

1,991

2,603

2,219

1,989

1,947

1,698

1,388

1,110

Short-term investments

55

274

525

802

603

524

184

50

260

279

304

349

179

66

299

249

749

499

-

-

0

-

-

-

Trade receivables, net

914

967

1,055

990

883

908

917

887

739

872

867

855

730

710

744

671

647

586

601

558

576

574

579

538

Inventories

296

297

299

296

285

280

274

269

272

265

259

261

249

242

242

239

229

219

201

219

213

229

235

262

Other current assets

694

653

631

548

493

440

468

508

448

463

458

479

482

451

449

393

376

334

331

376

368

318

323

359

Assets of discontinued operations

0

0

1

5

9

93

153

154

512

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

6,871

6,103

5,702

5,458

5,319

4,932

4,482

4,069

4,934

4,535

4,259

4,238

4,048

3,682

3,592

4,084

3,993

4,243

3,354

3,144

3,106

2,821

2,526

2,270

Investments and other assets

271

236

238

226

213

191

194

193

192

191

240

247

247

266

261

258

261

288

273

268

266

264

242

272

Deferred tax assets

86

59

121

121

128

120

88

74

206

188

159

149

152

151

249

242

217

157

17

6

0

-

-

-

Property, plant and equipment, net

1,006

1,005

977

942

923

877

866

853

851

822

811

807

807

791

795

788

800

778

785

795

808

785

781

775

Goodwill

2,392

2,414

2,340

2,339

2,339

2,334

2,326

2,313

2,133

2,092

2,090

2,097

2,088

2,093

2,050

2,045

2,038

2,043

1,996

2,008

1,998

2,000

1,970

1,981

Intangibles, net

1,786

1,826

1,609

1,632

1,650

1,689

1,716

1,745

860

1,079

1,111

1,144

1,165

1,198

930

951

996

1,029

1,360

1,405

1,357

1,391

1,417

1,491

Total assets

12,415

11,645

10,990

10,720

10,574

10,144

9,675

9,250

9,179

8,910

8,673

8,684

8,508

8,184

7,879

8,370

8,308

8,540

7,787

7,628

7,536

7,263

6,938

6,791

LIABILITIES AND EQUITY
Current liabilities:
Notes payable

72

55

60

61

55

37

51

57

48

40

42

87

83

78

76

36

28

18

13

17

18

16

12

4

Convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

648

642

636

629

-

0

-

-

-

Accounts payable

287

283

300

316

283

267

237

218

232

210

200

203

200

190

200

200

222

206

198

257

204

229

187

173

Accrued compensation

292

267

211

168

269

241

195

156

222

204

162

129

200

186

170

118

182

169

148

98

164

151

128

132

Accrued legal settlement expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

609

-

-

-

-

-

-

Other accrued expenses

905

960

833

702

597

632

610

624

586

596

558

548

470

467

474

471

436

432

386

388

382

354

336

336

Income taxes

0

0

0

0

38

16

-

-

0

2

-

-

-

0

0

0

16

21

43

20

42

4

15

49

Liabilities of discontinued operations

-

-

-

-

-

3

3

4

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

1,557

1,567

1,406

1,248

1,244

1,199

1,097

1,061

1,095

1,054

963

968

955

923

921

1,475

1,528

2,093

1,420

783

811

756

680

697

Long-term debt

2,085

2,088

2,091

2,095

2,098

2,101

2,104

2,107

1,512

1,515

1,514

1,514

1,515

1,516

1,510

1,529

1,534

1,546

888

877

874

881

875

885

Long-term convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

623

617

611

605

685

Deferred tax liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

1

14

24

69

Other liabilities

1,010

871

698

752

762

730

725

718

708

746

733

719

705

615

459

477

464

416

369

377

388

432

403

402

Commitments and contingencies

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

-

-

-

-

-

0

-

Equity:
Allergan, Inc. stockholders' equity:
Preferred stock, $.01 par value; authorized 5,000,000 shares; none issued

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $.01 par value; authorized 500,000,000 shares; issued 307,605,860 and 307,554,060 shares as of December 31, 2014 and 2013, respectively

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

Additional paid-in capital

3,353

3,249

3,193

3,124

3,032

3,005

2,975

2,951

2,900

2,854

2,824

2,794

2,761

2,725

2,702

2,828

2,815

2,774

2,751

2,736

2,730

2,711

2,691

2,596

Accumulated other comprehensive loss

-408

-293

-216

-224

-226

-252

-282

-265

-244

-244

-258

-218

-241

-179

-100

-131

-152

-105

-166

-122

-102

-154

-185

-198

Retained earnings

5,894

5,411

5,138

4,790

4,646

4,363

4,089

3,761

3,832

3,602

3,387

3,134

2,969

2,752

2,530

2,342

2,225

2,030

2,723

2,498

2,356

2,163

2,012

1,842

Stockholders' equity subtotal before treasury stock

8,843

8,371

8,119

7,694

7,456

7,119

6,786

6,450

6,491

6,215

5,956

5,713

5,492

5,301

5,135

5,042

4,891

4,702

5,311

5,115

4,987

4,723

4,522

4,243

Less treasury stock, at cost (8,373,176 and 9,947,345 shares as of December 31, 2014 and 2013, respectively)

1,090

1,260

1,333

1,076

992

1,033

1,064

1,113

654

645

517

255

183

196

171

176

133

243

223

170

164

176

175

192

Total stockholders' equity

7,753

7,110

6,786

6,617

6,463

6,085

5,721

5,337

5,837

5,569

5,438

5,458

5,309

5,105

4,963

4,865

4,757

4,459

5,088

4,944

4,822

4,546

4,346

4,050

Noncontrolling interest

10

8

8

7

6

27

25

25

25

24

22

22

22

22

24

22

23

24

21

21

21

20

2

1

Total equity

7,763

7,119

6,794

6,625

6,469

6,113

5,747

5,362

5,862

5,594

5,461

5,480

5,332

5,128

4,988

4,888

4,781

4,484

5,109

4,966

4,843

4,567

4,349

4,052

Total liabilities and equity

12,415

11,645

10,990

10,720

10,574

10,144

9,675

9,250

9,179

8,910

8,673

8,684

8,508

8,184

7,879

8,370

8,308

8,540

7,787

7,628

7,536

7,263

6,938

6,791